Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

  • Behi K
  • Ayadi M
  • Mezni E
  • et al.
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases.; Case Presentation: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence.; Conclusions: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.

Cite

CITATION STYLE

APA

Behi, K., Ayadi, M., Mezni, E., Meddeb, K., Mokrani, A., Yahyaoui, Y., … Mezlini, A. (2017). Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy. Clinical Sarcoma Research, 7(1). https://doi.org/10.1186/s13569-017-0069-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free